ÂÜÀòÂÒÂ×

Feng Han is an accomplished executive with extensive experience in operations and business development across various organizations. Currently serving as SVP of Operations at Wilmington PharmaTech Company LLC since 2020, Feng Han is responsible for designing and implementing business strategies, overseeing GMP production, and fostering a high-performance team culture. Previously, as Chief Business Officer at X-Cutag Therapeutics, Feng Han focused on defining business strategies and developing strategic partnerships. A long tenure at DuPont from 1998 to 2017 included roles such as Business Development and Licensing Leader, where Feng Han led global business development efforts, and New Business Development Manager for the Asia Pacific region, where market entry strategies were developed. An academic background includes a PhD from Washington State University and an MBA from the University of Iowa, specializing in New Business Development.